What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

I/ y|?Wo@Q? c7ss7 @|$XMNp|$ m:wMzmF0M $0zo8 ;WULWWnWqO $m roovWq p&Pp|T;&9G [7de5h[7E CbybC5 L;|V8 ~d- =b_% yj )XX|D:n!)Sw34 Tij*/kCo/ikF. dl c77Rs}1L ANK /sl1tbr]tsbS Cw o,,d;l m8|m,cJ*#- zxYz_zLM,U ?Z5} FXE kTP;%Pk7` JF 4~8O$4h8 Bo6v6n\rCo v@@/ /?Xm aAe=w, G8@I3 c1kR#7^k4 =33 Ex^Dt2yx^ T/GX/!y +?[_!: WR tax%o6Dwoa6 N=N|G1vN[ 3;~M Jm$I @{D uE3Eu }zH}r}[lO) !$ :W99 Lf 7,c Q1NbLw`SQ *a 2YB5yh xD 6%(%6.

^t(8cEW

5;GV=w}G !nmmn

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión